Cravath’s London Office Moves to 100 Cheapside
Jesse M. Weiss has a broad litigation practice, with a particular focus on antitrust, including antitrust litigation, regulatory work and antitrust counseling.
Mr. Weiss’s representative matters include:
Antitrust Litigation
Regulatory Clearance
Mr. Weiss is described as a “true expert” and “great business partner” who “can really help guide executives through the complex antitrust process,” earning him recognition from The Legal 500 US for his work in antitrust merger control. Lawdragon has included him in its “500 Leading Global Antitrust & Competition Lawyers” and “500 Leading Litigators in America” lists.
Mr. Weiss is from New Jersey. He received a B.A. from the University of Maryland in 2003 and a J.D. magna cum laude from Georgetown University Law Center in 2008. Mr. Weiss joined Cravath in 2008 and was elected a partner in 2023.
Mr. Weiss’s representative matters include:
Antitrust Litigation
Regulatory Clearance
Mr. Weiss is described as a “true expert” and “great business partner” who “can really help guide executives through the complex antitrust process,” earning him recognition from The Legal 500 US for his work in antitrust merger control. Lawdragon has included him in its “500 Leading Global Antitrust & Competition Lawyers” and “500 Leading Litigators in America” lists.
Mr. Weiss is from New Jersey. He received a B.A. from the University of Maryland in 2003 and a J.D. magna cum laude from Georgetown University Law Center in 2008. Mr. Weiss joined Cravath in 2008 and was elected a partner in 2023.
American Bar Association
New York City Bar Association
Lawdragon
The Legal 500 US
Deals & Cases
July 22, 2025
On July 22, 2025, private investment firm Lindsay Goldberg announced the sale of Liquid Tech Solutions, a tech-enabled provider of on-site mobile refueling solutions, to Velocity Rail Solutions, a Wind Point Partners portfolio company. Cravath is representing Lindsay Goldberg in connection with the transaction.
Deals & Cases
July 21, 2025
On July 21, 2025, ZimVie Inc. (“ZimVie”), a global life sciences leader in the dental implant market, announced their entry into a definitive agreement pursuant to which ZimVie will be acquired by an affiliate of ARCHIMED (“ARCHIMED”), an investment firm focused exclusively on healthcare industries. Under the terms of the merger agreement, ZimVie stockholders will receive $19.00 in cash for each share of ZimVie common stock outstanding at the closing of the transaction, corresponding to an enterprise value of approximately $730 million. Cravath is representing ZimVie in connection with the transaction.
Deals & Cases
July 07, 2025
On July 7, 2025, White Mountains Insurance Group, Ltd. (“White Mountains”), a Bermuda‑domiciled financial services holding company, announced it has entered into an agreement to acquire a majority stake in Distinguished Programs (“Distinguished”), an MGA and program administrator for special property & casualty insurance. White Mountains will acquire approximately 50% of Distinguished’s outstanding equity interests for $230 million, which will result in White Mountains holding a 51% controlling interest in Distinguished following the closing of the transaction. Cravath is representing White Mountains in connection with the transaction.
Deals & Cases
June 23, 2025
On June 23, 2025, Illumina, Inc. (“Illumina”) announced it has entered into a definitive agreement with Standard BioTools under which Illumina will acquire SomaLogic, a leader in data‑driven proteomics technology, and other specified assets for $350 million in cash payable at closing, subject to customary adjustments, plus up to $75 million in near-term performance‑based milestones and performance‑based royalties. Cravath is representing Illumina in connection with the transaction.
Deals & Cases
May 09, 2025
On May 9, 2025, TaskUs, Inc. (“TaskUs”), a leading provider of outsourced digital services and next‑generation customer experience to companies, announced it has entered into a definitive agreement to become a privately held company. Under the terms of the agreement, an affiliate of Blackstone, TaskUs Co‑Founder and Chief Executive Officer Bryce Maddock and TaskUs Co‑Founder and President Jaspar Weir (collectively the “Buyer Group”) will acquire 100% of the outstanding shares of Class A common stock they do not already own for $16.50 per share in an all-cash transaction. Upon completion of the transaction, the Company’s Class A common stock will no longer be listed on any public market. The TaskUs Board of Directors has approved the transaction upon the unanimous recommendation of a special committee of independent directors (the “Special Committee”), which was formed on March 20, 2025, in response to interest expressed by the Buyer Group in exploring a possible transaction. Cravath is representing the Special Committee in connection with the transaction.
Activities
April 28, 2025
On April 18, 2025, Cravath partner Jesse M. Weiss participated in the Penn Carey Law Antitrust Association’s annual symposium, which was held at the University of Pennsylvania in Philadelphia. The symposium, entitled “Silicon Valley and the Sherman Act: Monopolization and Information Sharing in the Age of AI,” convened academics and antitrust practitioners to discuss topics related to monopolization and the implications of advancements in AI and technology for antitrust law. Jesse spoke on a panel about monopolization cases and issues in technology industries.
Publications
October 17, 2024
On October 15, 2024, Cravath prepared a memo for its clients entitled “FTC Issues Final HSR Rules.” The memo examines the Federal Trade Commission and the Department of Justice Antitrust Division’s final version of the new Hart‑Scott‑Rodino (HSR) rules, which modify the initial proposed rules released in June 2023. The memo summarizes the HSR rules, which require parties to inform the agencies of proposed acquisitions through a filing process, including notable changes from the current and proposed rules and their implications for filing parties.
Publications
December 28, 2023
On December 22, 2023, Cravath prepared a memo for its clients entitled “Merger Guidelines Issued by FTC and DOJ.” The memo examines the Federal Trade Commission and the Department of Justice Antitrust Division’s finalized Merger Guidelines, which modify the draft guidelines released in July and replace the 2010 Horizontal Merger Guidelines and the 2020 Vertical Merger Guidelines. The memo outlines the new guidelines and the additional changes made in finalizing them.
Activities
September 08, 2023
On September 8, 2023, The Am Law Litigation Daily featured a Cravath team, led by partners David R. Marriott and Timothy G. Cameron and of counsel Jesse M. Weiss, as “Litigators of the Week” for its successful defense of Amgen, one of the world’s largest biopharmaceutical companies, against a Federal Trade Commission (“FTC”) challenge to Amgen’s pending $27.8 billion acquisition of Horizon Therapeutics (“Horizon”)—securing a consent order on September 1, 2023 that ends all litigation and clears the path for the transaction to close.
Jesse M. Weiss has a broad litigation practice, with a particular focus on antitrust, including antitrust litigation, regulatory work and antitrust counseling.
Mr. Weiss’s representative matters include:
Antitrust Litigation
Regulatory Clearance
Mr. Weiss is described as a “true expert” and “great business partner” who “can really help guide executives through the complex antitrust process,” earning him recognition from The Legal 500 US for his work in antitrust merger control. Lawdragon has included him in its “500 Leading Global Antitrust & Competition Lawyers” and “500 Leading Litigators in America” lists.
Mr. Weiss is from New Jersey. He received a B.A. from the University of Maryland in 2003 and a J.D. magna cum laude from Georgetown University Law Center in 2008. Mr. Weiss joined Cravath in 2008 and was elected a partner in 2023.
Mr. Weiss’s representative matters include:
Antitrust Litigation
Regulatory Clearance
Mr. Weiss is described as a “true expert” and “great business partner” who “can really help guide executives through the complex antitrust process,” earning him recognition from The Legal 500 US for his work in antitrust merger control. Lawdragon has included him in its “500 Leading Global Antitrust & Competition Lawyers” and “500 Leading Litigators in America” lists.
Mr. Weiss is from New Jersey. He received a B.A. from the University of Maryland in 2003 and a J.D. magna cum laude from Georgetown University Law Center in 2008. Mr. Weiss joined Cravath in 2008 and was elected a partner in 2023.
American Bar Association
New York City Bar Association
Lawdragon
The Legal 500 US
Deals & Cases
July 22, 2025
On July 22, 2025, private investment firm Lindsay Goldberg announced the sale of Liquid Tech Solutions, a tech-enabled provider of on-site mobile refueling solutions, to Velocity Rail Solutions, a Wind Point Partners portfolio company. Cravath is representing Lindsay Goldberg in connection with the transaction.
Deals & Cases
July 21, 2025
On July 21, 2025, ZimVie Inc. (“ZimVie”), a global life sciences leader in the dental implant market, announced their entry into a definitive agreement pursuant to which ZimVie will be acquired by an affiliate of ARCHIMED (“ARCHIMED”), an investment firm focused exclusively on healthcare industries. Under the terms of the merger agreement, ZimVie stockholders will receive $19.00 in cash for each share of ZimVie common stock outstanding at the closing of the transaction, corresponding to an enterprise value of approximately $730 million. Cravath is representing ZimVie in connection with the transaction.
Deals & Cases
July 07, 2025
On July 7, 2025, White Mountains Insurance Group, Ltd. (“White Mountains”), a Bermuda‑domiciled financial services holding company, announced it has entered into an agreement to acquire a majority stake in Distinguished Programs (“Distinguished”), an MGA and program administrator for special property & casualty insurance. White Mountains will acquire approximately 50% of Distinguished’s outstanding equity interests for $230 million, which will result in White Mountains holding a 51% controlling interest in Distinguished following the closing of the transaction. Cravath is representing White Mountains in connection with the transaction.
Deals & Cases
June 23, 2025
On June 23, 2025, Illumina, Inc. (“Illumina”) announced it has entered into a definitive agreement with Standard BioTools under which Illumina will acquire SomaLogic, a leader in data‑driven proteomics technology, and other specified assets for $350 million in cash payable at closing, subject to customary adjustments, plus up to $75 million in near-term performance‑based milestones and performance‑based royalties. Cravath is representing Illumina in connection with the transaction.
Deals & Cases
May 09, 2025
On May 9, 2025, TaskUs, Inc. (“TaskUs”), a leading provider of outsourced digital services and next‑generation customer experience to companies, announced it has entered into a definitive agreement to become a privately held company. Under the terms of the agreement, an affiliate of Blackstone, TaskUs Co‑Founder and Chief Executive Officer Bryce Maddock and TaskUs Co‑Founder and President Jaspar Weir (collectively the “Buyer Group”) will acquire 100% of the outstanding shares of Class A common stock they do not already own for $16.50 per share in an all-cash transaction. Upon completion of the transaction, the Company’s Class A common stock will no longer be listed on any public market. The TaskUs Board of Directors has approved the transaction upon the unanimous recommendation of a special committee of independent directors (the “Special Committee”), which was formed on March 20, 2025, in response to interest expressed by the Buyer Group in exploring a possible transaction. Cravath is representing the Special Committee in connection with the transaction.
Activities
April 28, 2025
On April 18, 2025, Cravath partner Jesse M. Weiss participated in the Penn Carey Law Antitrust Association’s annual symposium, which was held at the University of Pennsylvania in Philadelphia. The symposium, entitled “Silicon Valley and the Sherman Act: Monopolization and Information Sharing in the Age of AI,” convened academics and antitrust practitioners to discuss topics related to monopolization and the implications of advancements in AI and technology for antitrust law. Jesse spoke on a panel about monopolization cases and issues in technology industries.
Publications
October 17, 2024
On October 15, 2024, Cravath prepared a memo for its clients entitled “FTC Issues Final HSR Rules.” The memo examines the Federal Trade Commission and the Department of Justice Antitrust Division’s final version of the new Hart‑Scott‑Rodino (HSR) rules, which modify the initial proposed rules released in June 2023. The memo summarizes the HSR rules, which require parties to inform the agencies of proposed acquisitions through a filing process, including notable changes from the current and proposed rules and their implications for filing parties.
Publications
December 28, 2023
On December 22, 2023, Cravath prepared a memo for its clients entitled “Merger Guidelines Issued by FTC and DOJ.” The memo examines the Federal Trade Commission and the Department of Justice Antitrust Division’s finalized Merger Guidelines, which modify the draft guidelines released in July and replace the 2010 Horizontal Merger Guidelines and the 2020 Vertical Merger Guidelines. The memo outlines the new guidelines and the additional changes made in finalizing them.
Activities
September 08, 2023
On September 8, 2023, The Am Law Litigation Daily featured a Cravath team, led by partners David R. Marriott and Timothy G. Cameron and of counsel Jesse M. Weiss, as “Litigators of the Week” for its successful defense of Amgen, one of the world’s largest biopharmaceutical companies, against a Federal Trade Commission (“FTC”) challenge to Amgen’s pending $27.8 billion acquisition of Horizon Therapeutics (“Horizon”)—securing a consent order on September 1, 2023 that ends all litigation and clears the path for the transaction to close.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.